OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ALK-Abello A/S/  DK0061802139  /

Cboe Europe DXE
2024-10-25  4:54:50 PM Chg. +1.20 Volume Bid4:55:00 PM Ask4:55:00 PM Market Capitalization Dividend Y. P/E Ratio
166.50DKK +0.73% 27,832
Turnover: 1.66 mill.		 -Bid Size: - -Ask Size: - 36.69 bill.DKK - 75.41
GlobeNewswire 08-22 Six-month interim report (Q2) 2024
GlobeNewswire 08-22 ALK upgrades its full-year revenue and earnings outlook
GlobeNewswire 06-03 ALK launches new growth strategy and 2028 financial ambitions
GlobeNewswire 05-02 Three-month interim report (Q1) 2024 (unaudited) 
GlobeNewswire 02-16 Annual General Meeting in ALK-Abelló A/S on 14 March 2024
GlobeNewswire 02-08 Annual report 2023: ALK delivers 9% sales growth with profits up 50%
GlobeNewswire 02-05 ALK’s 2030 CO2 reduction targets have been approved by SBTi
GlobeNewswire 01-18 ALK completes first part of phase 1 trial with peanut SLIT-tablet
GlobeNewswire 2023-11-15 Nine-month interim report (Q3) 2023
GlobeNewswire 2023-08-24 Six-month interim report (Q2) 2023
GlobeNewswire 2022-03-03 Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy ta...
GlobeNewswire 2022-02-21 Annual General Meeting in ALK-Abelló A/S on 16 March 2022
GlobeNewswire 2022-02-08 Annual report 2021: ALK delivers strong sales growth of 12% with tablet sales up 29% and EBITDA up 3...
GlobeNewswire 2021-08-11 Six-month interim report (Q2) 2021
GlobeNewswire 2021-08-09 ALK upgrades its full-year financial outlook
GlobeNewswire 2021-08-04 Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-07-30 ALK and Grandpharma team up to market the first adrenaline autoinjector in China
GlobeNewswire 2021-05-11 Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-02-11 Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
GlobeNewswire 2021-02-10 ALK releases 2020 annual report
GlobeNewswire 2020-11-11 Nine-month interim report (Q3) 2020
GlobeNewswire 2020-11-05 ALK updates its full-year financial outlook
GlobeNewswire 2020-08-12 Six-month interim report (Q2) 2020
GlobeNewswire 2020-08-04 Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire 2020-06-15 Otonomy Provides Update on Clinical Trials and Development Programs